Elite Laboratories recalls
Elite Laboratories appears in 1 official U.S. recall notice indexed by RecallRadar, most recently on 2017-12-13.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 1 |
|---|---|
| Published | 2017-12-13 |
| By agency | FDA Drug (1) |
| By classification | Class III (1) |
| By status | terminated (1) |
| Distribution named in notices | NY |
Recalls
- Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc
FDA Drug · Class III · 2017-12-13 · Elite Laboratories
Reason: Failed Impurities/Degradation Specifications